Last reviewed · How we verify
NCT07187596: MOCH
Mortality Outcome of Controlled Hypertension
trial in Hypertension in 2,547 participants. Participants enrolled and being followed up; not accepting new ones.
18 December 2026
Quick facts
| Lead sponsor | DejthidaNathaphong |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 2,547 |
| Start date | 18 September 2025 |
| Primary completion | 18 December 2026 |
| Estimated completion | 14 December 2027 |
| Sites | 1 location across Thailand |
Conditions studied
- Hypertension — all drugs for Hypertension →
- Morality — all drugs for Morality →
- Death — all drugs for Death →
- Pre-Eclampsia — all drugs for Pre-Eclampsia →
Sponsor
DejthidaNathaphong
Who can join
Adults 1 Minute to 130, any sex, with Hypertension or Morality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pooled analysis investigates death outcomes in patients with pharmacologically treated and blood pressure-controlled hypertension. Despite documented BP control, some patients still suffer fatal cardiovascular, cerebrovascular, renal, or unexplained syndromes. This study aims to synthesize available evidence across study types to identify treatment pitfalls, contributing syndromes, and non-BP factors associated with these fatal outcomes. February 14th, 2026. Total search hits: 9,297 articles from your hypertension-mortality PubMed strategy Working dataset: 2,547 unique records. Screened so far: 50 (2.0%). Mostly excluded because: Not the right treatment strategy. No mortality outcome. Less often: wrong population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07187596
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other DejthidaNathaphong trials
Trials by the same sponsor.
- NCT07067632 — To Study the Mortality Outcome of Controlled Blood Pressure Participants · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07187596 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by DejthidaNathaphong
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07187596.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing